Current Edition

2018

Lilly to Present Phase 3 Data at AHS 2018 Highlighting Innovative Potential Treatments for Migraine and Cluster Headache

Eli Lilly and Company (NYSE: LLY) announced today it will present Phase 3 data for galcanezumab and lasmiditan, two investigational, non-opioid treatments for migraine and cluster …

Continue Reading →
2018

ASCO 2018: CarThera presents promising preliminary efficacy data for treating recurrent glioblastoma

Preliminary data from the first clinical trial of the company’s intracranial ultrasound implant, SonoCloud®, show a good safety profile and promising trends in overall survival …

Continue Reading →
2018

Clinical Innovation Partnerships 2018

When: 03 – 04 July, 2018 Where: Radisson Blu Hotel, Zurich Airport The only event for senior Clinical Operations and Procurement professionals driving innovation in …

Continue Reading →
2018

Budget 2018: Boost for clinical trials as patients speak about life as human guinea pigs

For people with chronic or incurable conditions, there’s only one thing scarier than the experimental treatments involved in a clinical trial — getting the placebo. …

Continue Reading →
2018

Outsourcing In Clinical Trials UK & Ireland 2018

Streamline & Innovate Clinical Trials Operations Against A Backdrop of Shifting Priorities and Political Change The 5th Annual Outsourcing in Clinical Trials UK & Ireland …

Continue Reading →